0001599298-20-000044.txt : 20201123
0001599298-20-000044.hdr.sgml : 20201123
20201120185517
ACCESSION NUMBER: 0001599298-20-000044
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201123
DATE AS OF CHANGE: 20201120
EFFECTIVENESS DATE: 20201123
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-381239
FILM NUMBER: 201333820
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
D
1
primary_doc.xml
X0708
D
LIVE
0001599298
Summit Therapeutics Inc.
ONE BROADWAY
14TH FLOOR
CAMBRIDGE
MA
MASSACHUSETTS
02142
617-514-7149
DELAWARE
Summit Therapeutics plc
Summit Corp plc
Corporation
true
2020
Robert
Duggan
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Mr. Duggan is the Issuer's Chief Executive Officer and Executive Chairman and was one of three investors in the offering.
Mahkam
Zanganeh
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Director
Rainer
Erdtmann
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Director
Manmeet
Soni
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Director
Ujwala
Mahatme
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Director
Michael
Paul
Donaldson
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Houbiers
Jos
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
David
Johnathan
Powell
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Camilla
Graham
One Broadway
14th Floor
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Biotechnology
$1,000,001 - $5,000,000
- 06b
false
2020-11-06
false
true
false
0
50000000
50000000
0
false
3
0
0
0
false
Summit Therapeutics Inc.
/s/Michael Donaldson
Michael Donaldson
Chief Financial Officer
2020-11-20